NCT01025713View on ClinicalTrials.gov

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions

Cystic FibrosisMucociliary Clearance

Interventions

DRUG

GS-9411

Inhaled GS-9411

DRUG

Placebo

Inhaled Placebo

Trial Locations (1)

Unknown

Nucleus Network, Ltd., Melbourne

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY